Is Wastewater-Derived Bioplastic Utility-Ready?

By Edgar Galindo de Moura

A staged framework for utilities evaluating wastewater-derived polyhydroxyalkanoates (PHA).

For years, researchers focused on a basic question: Can mixed microbial cultures use real wastewater or sludge-derived carbon to accumulate polyhydroxyalkanoates (PHA) inside their cells? Recent evidence has strengthened the answer. Studies include a 200-day pilot using waste activated sludge, a 4-cubic-meter demonstration with industrially relevant equipment, and other pilot configurations using fermented sludge-derived feedstocks.^1-3

For a utility, however, biological accumulation is only the first step. It does not show whether operators can recover PHA from the biomass, meet product specifications, find a buyer, protect treatment, and justify the costs and environmental claims. A facility can absorb technical, treatment, and market risks long before it sells recovered polymer. Wastewater-derived PHA may represent a short- to medium-term resource-recovery opportunity for selected utilities, but each facility must demonstrate readiness stage by stage.

Pilot Success Changed The Question

Pilot and demonstration studies now show that real municipal residuals can support PHA production beyond laboratory scale. Real streams differ from synthetic feedstocks. They expose the process to seasonal variation, competing organisms, changing carbon composition, and operating constraints. Longer trials also answer a practical question: Can the microbial community remain productive as those conditions change, rather than produce only one successful batch?

Scale-up has also revealed control problems that may be less visible in a small reactor. In the 4-cubic-meter demonstration, heat generation and foaming required particular attention. Other recent studies show that carbon-to-nitrogen balance, pH, dissolved oxygen, loading, and cycle control can affect PHA accumulation, nitrogen removal, emissions, and the composition of the accumulated polymer.^2,4,5

These findings do not weaken the case for PHA. They show what a utility must learn before routine production. Pilot success therefore justifies investigation; by itself, it does not justify a purchasing or commercial commitment. A utility must answer two separate questions: Can the microorganisms accumulate PHA inside the biomass, and can the entire pathway perform consistently under the facility's actual conditions?

Yield Is Not Readiness

The first readiness gate must protect the utility's core mission. A PHA process should not compromise worker safety, treatment stability, or effluent compliance. If higher polymer accumulation coincides with weaker nitrogen removal, unacceptable emissions, unstable operation, or a poorer effluent, the facility has not achieved operational success. Recent pilot comparisons illustrate that these outcomes can move differently even when PHA production appears favorable.⁵

The second gate concerns the real feedstock and the controls needed to manage it. A utility should characterize carbon availability, nutrient balance, variability, temperature behavior, oxygen demand, foaming, and the effect of the new process on existing treatment. Automation and real-time monitoring can support stability and reduce interruption risk, but they cannot guarantee uninterrupted operation or replace trained operators.

The third gate begins where many biological studies end: recovery and product quality. PHA content inside biomass is not a saleable product. Extraction method can alter recovery, purity, molecular properties, thermal behavior, chemical demand, and residual generation. A 2025 comparison of eight recovery approaches found material trade-offs; no single approach dominated every criterion.⁶ Product variability may be managed through buyer-defined specifications, purification, formulation, or blending, but it cannot be treated as commercially irrelevant.

Contaminant transfer through PHA-rich biomass, extraction, recovered polymer, and residual streams also remains a research question. Current evidence does not justify assuming either that the recovered polymer is contaminated or that transfer will be immaterial. A pilot should define testing appropriate to its feedstock and intended product use without turning an unresolved question into an unsupported conclusion.

Choose The Right Operating Boundary

A utility does not need to own the entire value chain on the first day. The most attainable initial model may be biological production at the treatment facility, supported by a specialist that handles some combination of biomass stabilization, extraction, purification, formulation, quality assurance, and marketing. This arrangement lets the utility develop operating knowledge while placing unfamiliar downstream tasks with an organization prepared to manage them.

That model may also create a participation path for smaller utilities. A smaller facility could produce PHA-rich biomass and transfer it to a qualified central processor rather than install a complete recovery and commercialization line. Research has shown that acidification or drying can stabilize PHA-rich biomass for later processing, although storage method can affect polymer properties.⁷ Demonstration and modeling work also suggest potential scale and quality-control advantages from central processing.^2,8

This central-processing approach remains a configuration to test, not a proven United States best practice. The business case depends on storage duration, solids concentration, transportation distance, odors, safety, rejected batches, processor acceptance specifications, ownership, and liability. Moving wet material over long distances could erase the economic or environmental benefit that central processing was intended to create.

Internal processing may become attractive later. A utility that internalizes recovery, purification, formulation, and commercialization may retain more product value and avoid third-party margins. It also assumes the associated capital, labor, quality, sales, liability, and market risks. Downstream-process models show that route selection and scale can materially change cost and environmental performance.^8,9 Internal processing improves net viability only when the value retained exceeds those additional costs and risks. That is a site- and scale-dependent opportunity, not a generally more profitable model.

Test The Full Business And Environmental Case

A credible business case must separate four categories: product revenue, avoided costs, quantified co-benefits, and public support. Combining them into one positive number can hide whether the product itself creates value. The analysis should include capital recovery, labor, energy, chemicals, transport, specialist services, quality assurance, residual management, financing, downtime, rejected material, and market risk. Modeled production costs are useful for screening, but they are not observed commercial costs for specification-grade polymer.

Before commercial-scale commitment, the utility should have more than general market interest. A credible buyer should identify the required product specification, expected volume, acceptable price range, qualification process, duration of demand, and responsibility for off-specification material. Without a credible buyer, commercial production has no defensible destination.

The mature objective should be direct profit after full-cost accounting. During start-up, operation near break-even may be reasonable when the learning period is defined or when quantified operational or environmental co-benefits compensate for the gap. Public funding can enable pilots, capital development, or policy objectives involving alternatives to petroleum-derived products. It should not become the sole indefinite basis for routine operation.

Environmental claims require equally complete boundaries. A wastewater-derived polymer should be compared with both the alternative use or disposition of the sludge or carbon and the petroleum-derived product or function it could displace. Comparing only with fossil-based plastic may ignore the benefits lost when carbon is diverted from anaerobic digestion or another recovery route.

Recent lifecycle scenarios demonstrate why this matters. One 2025 analysis found anaerobic digestion environmentally preferable to sludge-derived PHA under the conditions assessed, while changes in the future electricity system altered parts of the comparison.¹⁰ Another modeling study found a sludge-to-volatile-fatty-acid route preferable to the assessed PHA and protein-recovery scenarios, with separation and purification chemicals contributing important burdens.¹¹ These studies do not establish a universal ranking. They show that “bio-based” and “biodegradable” are starting characteristics, not complete sustainability conclusions.

Scale Through Explicit Decision Gates

A selected utility can investigate this opportunity now without jumping directly to commercial scale. A disciplined path has five stages:

1. Characterize the actual substrate, its variability, current carbon uses, treatment constraints, and potential product requirements.
2. Run a controlled on-site pilot that isolates risk and demonstrates that safety, treatment performance, and effluent compliance remain protected.
3. Qualify the downstream processor and a credible buyer, including specifications, responsibilities, residuals, and rejected-batch procedures.
4. Where appropriate, test distributed biological production with central processing, measuring storage, logistics, quality, cost, and environmental effects.
5. Expand internal processing or joint operation only after stable performance, acceptable product quality, reliable offtake, and full-cost economics have been demonstrated.

The stop rules should be just as clear. A threat to safety, treatment, or compliance requires the utility to stop or isolate the process. The absence of a credible buyer is a commercial no-go, even if research can continue. Persistent inability to meet the mature full-cost threshold should trigger a pause, redesign, or termination of expansion.

Three capabilities will determine how far this pathway can move: regional logistics and scheduled central processing; early buyer and market development; and automation, real-time monitoring, and process control. Their evidence bases are not equally mature, but each addresses a failure point that polymer yield alone cannot solve.

Wastewater-derived PHA is not utility-ready everywhere. It is ready for selected utilities to ask better questions, characterize their streams, identify partners and buyers, and begin controlled pilots. Smaller facilities may participate without owning the full chain, while larger or more experienced utilities may adopt internal processing of additional stages when doing so creates net value. The opportunity may be real, but utility readiness must be demonstrated stage by stage.

References

1. Mineo, A., van Loosdrecht, M. M. C., & Mannina, G. (2025). “From waste activated sludge to polyhydroxyalkanoate: Insights from a membrane-based enrichment process.” Chemical Engineering Journal, 506, 160089. https://doi.org/10.1016/j.cej.2025.160089.
2. Pei, R., de Vries, E., Estévez, A., Sousa, J., Dijkman, H., Tamis, J., & Werker, A. (2025). “Demonstrating performance in scaled-up production and quality control of polyhydroxyalkanoates using municipal waste activated sludge.” Water Research, 275, 123160. https://doi.org/10.1016/j.watres.2025.123160.
3. He, Y., et al. (2025). “Pilot-scale investigation of polyhydroxyalkanoates synthesis using mixed microbial cultures from fermented thermally hydrolyzed sludge.” Bioresource Technology, 133157. https://doi.org/10.1016/j.biortech.2025.133157.
4. Mineo, A., van Loosdrecht, M. M. C., & Mannina, G. (2025). “Assessing the aerobic/anoxic enrichment efficiency at different C/N ratios: Polyhydroxyalkanoate production from waste activated sludge.” Water Research, 268, 122687. https://doi.org/10.1016/j.watres.2024.122687.
5. Mineo, A., van Loosdrecht, M. M. C., & Mannina, G. (2025). “Comparing two advanced selection strategies for polyhydroxyalkanoate production from domestic waste activated sludge.” Chemical Engineering Journal, 513, 163046. https://doi.org/10.1016/j.cej.2025.163046.
6. Inoue, D., Miwa, K., & Ike, M. (2025). “Comparative evaluation of polyhydroxyalkanoates recovery methods for a mixed microbial culture derived from waste activated sludge.” Journal of Material Cycles and Waste Management, 27, 2887-2898. https://doi.org/10.1007/s10163-025-02242-3.
7. Lorini, L., Martinelli, A., Pavan, P., Majone, M., & Valentino, F. (2021). “Downstream processing and characterization of polyhydroxyalkanoates produced by mixed microbial culture and organic urban waste as substrate.” Biomass Conversion and Biorefinery, 11, 693-703. https://doi.org/10.1007/s13399-020-00788-w.
8. Roibás-Rozas, A., Saavedra del Oso, M., Posada, J. A., Mosquera-Corral, A., & Hospido, A. (2023). “A circular economy strategy for valorizing industrial saline wastewaters: Techno-economics and environmental impacts.” Chemical Engineering Journal, 472, 144819. https://doi.org/10.1016/j.cej.2023.144819.
9. Fernández-Dacosta, C., Posada, J. A., Kleerebezem, R., Cuellar, M. C., & Ramirez, A. (2015). “Microbial community-based polyhydroxyalkanoates production from wastewater: Techno-economic analysis and ex-ante environmental assessment.” Bioresource Technology, 185, 368-377. https://doi.org/10.1016/j.biortech.2015.03.025.
10. O'Maolduin, C., Compeer, A., de Best, J., Gill, L., Ali, M., & Gallagher, J. (2025). “The circular value of polyhydroxyalkanoate bioplastic production from sludge at a large-scale wastewater treatment plant.” Bioresource Technology Reports, 31, 102272. https://doi.org/10.1016/j.biteb.2025.102272.
11. Zhou, H., Wang, Z., Liu, B., et al. (2025). “Sustainability of emerging sludge resource recovery scenarios: Process modeling and life cycle assessment.” Resources, Conservation and Recycling, 215, 108165. https://doi.org/10.1016/j.resconrec.2025.108165.

Edgar Galindo de Moura is a chemistry-trained water and sanitation professional with more than 16 years of sector experience. He has worked at Companhia de Saneamento Básico do Estado de São Paulo (SABESP) since 2010 in water-system operations and previously participated in the project to implement a 30,000-liter-per-day wastewater treatment plant at Produquímica, now part of ICL Group. He holds a bachelor's degree in chemistry and postgraduate training in environmental engineering and basic sanitation. His 2023 published literature review examined polyhydroxybutyrate (PHB) biodegradation and sustainable-production constraints.

Click here for more Water Innovations articles.